Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Inflammation and Gut Health in Obese Adults
NCT03418857Phase 2Recruiting
- Sponsor
- The Pennsylvania State University
- Start
- Jun 2018
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by The Pennsylvania State University. Primary endpoint: Change from baseline in inflammatory markers at 12 weeks. Started Jun 2018; status: recruiting.
Beyond the preview
Go deeper on NCT03418857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418857.